z-logo
open-access-imgOpen Access
Comparison of Plasma Phosphorylated Tau Species With Amyloid and Tau Positron Emission Tomography, Neurodegeneration, Vascular Pathology, and Cognitive Outcomes
Author(s) -
Michelle M. Mielke,
Ryan D. Frank,
Jeffrey L. Dage,
Andreas Jeromin,
Nicholas J. Ashton,
Kaj Blennow,
Thomas K. Karikari,
Eugeen Vanmechelen,
Henrik Zetterberg,
Alicia AlgecirasSchimnich,
David S. Knopman,
Val J. Lowe,
Guojun Bu,
Prashanthi Vemuri,
Jonathan GraffRadford,
Clifford R. Jack,
Ronald C. Petersen
Publication year - 2021
Publication title -
jama neurology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.298
H-Index - 231
eISSN - 2168-6157
pISSN - 2168-6149
DOI - 10.1001/jamaneurol.2021.2293
Subject(s) - standardized uptake value , interquartile range , positron emission tomography , medicine , fractional anisotropy , white matter , hyperintensity , pathology , magnetic resonance imaging , nuclear medicine , psychology , radiology
Cerebrospinal fluid phosphorylated tau (p-tau) 181, p-tau217, and p-tau231 are associated with neuropathological outcomes, but a comparison of these p-tau isoforms in blood samples is needed.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom